Drugmakers begin effort to get OTC status for statin drugs in U.S.

05/14/2004 | ABC

Now that Britain has approved over-the-counter sales of anti-cholesterol statin drugs, the world's largest pharmaceutical companies are turning their sights to the U.S., where they already have begun lobbying for a similar decision. Johnson & Johnson-Merck Consumer Pharmaceuticals, a joint venture promoting FDA approval of OTC status for statins, is beginning its effort to get a low-dose version of its first statin drug, Mevacor, in the hands of people considered at 10% to 20% risk of having cholesterol problems.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Associate Manager, Regulatory Affairs
Mahwah, NJ
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC